Genome-wide association studies in ADHD by Franke, Barbara et al.
 Genome-wide association studies in ADHD
 
 
(Article begins on next page)
The Harvard community has made this article openly available.
Please share how this access benefits you. Your story matters.
Citation Franke, Barbara, Benjamin M. Neale, and Stephen V. Faraone.
2009. “Genome-wide association studies in ADHD.” Human
Genetics 126 (1): 13-50. doi:10.1007/s00439-009-0663-4.
http://dx.doi.org/10.1007/s00439-009-0663-4.
Published Version doi:10.1007/s00439-009-0663-4
Accessed February 19, 2015 2:32:57 PM EST
Citable Link http://nrs.harvard.edu/urn-3:HUL.InstRepos:11877080
Terms of Use This article was downloaded from Harvard University's DASH
repository, and is made available under the terms and conditions




Genome-wide association studies in ADHD
Barbara Franke Æ Benjamin M. Neale Æ
Stephen V. Faraone
Received: 21 January 2009 / Accepted: 27 March 2009 / Published online: 22 April 2009
 The Author(s) 2009. This article is published with open access at Springerlink.com
Abstract Attention-deficit/hyperactivity disorder, ADHD,
is a common and highly heritable neuropsychiatric disorder
that is seen in children and adults. Although heritability is
estimated at around 76%, it has been hard to find genes
underlying the disorder. ADHD is a multifactorial disorder,
in which many genes, all with a small effect, are thought to
cause the disorder in the presence of unfavorable envi-
ronmental conditions. Whole genome linkage analyses
have not yet lead to the identification of genes for ADHD,
and results of candidate gene-based association studies
have been able to explain only a tiny part of the genetic
contribution to disease, either. A novel way of performing
hypothesis-free analysis of the genome suitable for the
identification of disease risk genes of considerably smaller
effect is the genome-wide association study (GWAS). So
far, five GWAS have been performed on the diagnosis of
ADHD and related phenotypes. Four of these are based on
a sample set of 958 parent–child trio’s collected as part of
the International Multicentre ADHD Genetics (IMAGE)
study and genotyped with funds from the Genetic Associ-
ation Information Network (GAIN). The other is a pooled
GWAS including adult patients with ADHD and controls.
None of the papers reports any associations that are for-
mally genome-wide significant after correction for multiple
testing. There is also very limited overlap between studies,
apart from an association with CDH13, which is reported in
three of the studies. Little evidence supports an important
role for the ‘classic’ ADHD genes, with possible excep-
tions for SLC9A9, NOS1 and CNR1. There is extensive
overlap with findings from other psychiatric disorders.
Though not genome-wide significant, findings from the
individual studies converge to paint an interesting picture:
whereas little evidence—as yet—points to a direct
involvement of neurotransmitters (at least the classic
dopaminergic, noradrenergic and serotonergic pathways)
or regulators of neurotransmission, some suggestions are
found for involvement of ‘new’ neurotransmission and
cell–cell communication systems. A potential involvement
of potassium channel subunits and regulators warrants
further investigation. More basic processes also seem
involved in ADHD, like cell division, adhesion (especially
via cadherin and integrin systems), neuronal migration, and
neuronal plasticity, as well as related transcription, cell
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polarity and extracellular matrix regulation, and cytoskele-
tal remodeling processes. In conclusion, the GWAS per-
formed so far in ADHD, though far from conclusive,
provide a first glimpse at genes for the disorder. Many
more (much larger studies) will be needed. For this, col-
laboration between researchers as well as standardized
protocols for phenotyping and DNA-collection will
become increasingly important.
Review
Attention-deficit/hyperactivity disorder (ADHD) is a
common neuropsychiatric disorder. The prevalence of the
disorder in children is estimated at 5.3%, estimates for
adults vary from 1 to 4% (Faraone et al. 2000b; Kessler
et al. 2006; Kooij et al. 2005; Polanczyk and Rohde 2007).
A large number of studies, including family, adoption and
twin studies suggest that ADHD is among the most heri-
table of neuropsychiatric disorders: ADHD was found to
segregate in families with different studies finding risk
increases of two to eightfold for parents and siblings of
affected children (reviewed by Faraone and Doyle 2001).
Adoption studies showed that the biological parents of
hyperactive children carry a higher risk for ADHD com-
pared to adoptive parents (Cantwell 1975; Morrison and
Stewart 1973), and that first-degree adoptive relatives of
probands with ADHD have a lower disease risk than the
first-degree biological relatives of non-adopted ADHD
probands (Sprich et al. 2000). More than 20 twin studies
have been published in the last 32 years, most reporting
estimates of heritability for ADHD between 60 and nearly
100%, with a mean of 76% (Faraone et al. 2005; Haber-
stick et al. 2008; Heiser et al. 2006; McLoughlin et al.
2007; Schultz et al. 2006).
The genetic architecture of ADHD is not currently clear.
A polygenic transmission model seems likely (Faraone and
Doyle 2001; Morrison and Stewart 1974), although some
authors have suggested more dominant gene effects
(Acosta et al. 2004; Deutsch et al. 1990; Maher et al. 1999;
Morrison and Stewart 1974). Since it is also known that
environmental factors play a role in ADHD etiology (for
review see Banerjee et al. 2007), the disorder seems best
described as being of multifactorial origin.
Identifying the individual genes contributing to the
genetic variance of ADHD has proven difficult. Two
approaches have been available for this type of research
until recently: hypothesis-driven candidate gene associa-
tion studies and hypothesis-free genome-wide linkage
analysis. Although hundreds of candidate gene studies have
been reported (see for example Bobb et al. 2005; Khan and
Faraone 2006), only a handful of associations have been
replicated across studies, although none of these achieved
genome-wide significance (e.g. Faraone et al. 2005; Li
et al. 2006). These studies have mainly concentrated on
genes involved in neurotransmission, particularly in the
catecholaminergic systems involved in the response to
ADHD medications. Clearly, the hypothesis-driven
approach has been limited by our restricted knowledge
regarding mechanisms involved in ADHD pathogenesis.
Genome-wide, hypothesis-free linkage analysis has been
performed in ADHD using qualitative and quantitative
definitions of the disease phenotype (Arcos-Burgos et al.
2004; Asherson et al. 2008; Bakker et al. 2003; Hebebrand
et al. 2006; Ogdie et al. 2003; Ogdie et al. 2004; Ogdie
et al. 2006; Romanos et al. 2008; Zhou et al. 2008a), and
recently also using ADHD endophenotypes at the level of
neuropsychological functioning (Doyle et al. 2008;
Rommelse et al. 2008c). Although linkage designs have
been highly successful in the identification of genes for
monogenic diseases, this has not been the case for poly-
genic or multifactorial disorders. The linkage studies in
ADHD have identified a number of genetic loci (poten-
tially) harboring genes for ADHD, but very little overlap
was observed between studies, so far. A recent meta-
analysis of ADHD linkage studies only confirmed one
locus, on chromosome 16 (Zhou et al. 2008c).
Generally, the results of both candidate gene-based
association studies and genome-wide linkage studies have
not identified major genes for ADHD. In candidate gene
studies, individual gene variants have only shown small
effects, rarely reaching an odds ratio of 1.3 (e.g. Faraone
et al. 2005). This strongly limits the power of genetic
linkage designs in ADHD research, as these designs are
suited for the identification of individual genetic variants
that explain at least 10% of the genetic variance of a trait or
disease (Risch and Merikangas 1996). A situation like this
calls for a new analytic approach, one which combines the
power to detect genetic variants of small effect size, like
the association studies, with the possibility to perform
hypothesis-free analyses of the entire genome. This has
recently become feasible using the genome-wide associa-
tion study (GWAS) methodology. In GWAS, 100,000 to
more than 1,000,000 genetic variants (in this case single
nucleotide polymorphisms, SNPs), distributed across the
entire genome are genotyped using a microarray platform
and (individually) tested for association with a trait or
disorder. The selection of SNPs is mostly based on the
distribution of linkage disequilibrium (LD) across the
genome, as identified by the HapMap project (Frazer et al.
2007; The International HapMap Consortium 2005). This
selection is sufficient to obtain information about most of
the frequent genetic variation in the genome (Manolio et al.
2008; Pearson and Manolio 2008), especially for the newer
platforms, which include around 1,000,000 or more SNPs.
14 Hum Genet (2009) 126:13–50
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In the short time of their existence, GWAS have already
led to the identification of more than 100 genetic variants
significantly associated with about 40 different traits and
diseases, including a number of psychiatric ones (e.g.
Ferreira et al. 2008; O’Donovan et al. 2008; O’Donovan
et al. 2009; Sklar et al. 2008). Although highly successful,
design-wise (for an overview of GWAS approaches see
Neale and Purcell 2008), the GWAS method has not been
exploited to the fullest, given its high financial costs
(sample sizes of several thousands to ten-thousands may be
needed, see for a recent discussion of this matter Burton
et al. 2008). Major progress in the field came through a
number of GWAS initiatives funded by government and
industry, like the Welcome Trust Case Control Consortium
(WTCCC; 2007) and the Genetic Association Information
Network (GAIN; Manolio et al. 2007). Among the 13
diseases that were analyzed in the first rounds of these two
initiatives, the WTCCC included 1 and GAIN included 4
psychiatric disorders.
GAIN has also been the setting for the first GWAS in
ADHD, which was carried out in 958 Caucasian case–
parent-trios collected as part of the International Multi-
centre ADHD Genetics (IMAGE) study in children
(Brookes et al. 2006; Kuntsi et al. 2006). Using the geno-
typing data from this study, Neale et al. (2008a) reported a
classic transmission disequilibrium analysis (TDT) of a
categorically defined ADHD phenotype. In addition,
Lasky-Su et al. (2008b) performed an analysis using
quantitative measures of ADHD symptoms. In the mean-
time, a second set of genome-wide data has been reported
by Lesch and coworkers. These researchers used pools of
DNA from 343 ADHD-affected adults and 304 controls for
their genome-wide association analysis of a categorical
ADHD phenotype (Lesch et al. 2008). Following the first
analyses, the GAIN/IMAGE ADHD dataset has since been
used for a number of exploratory studies using additional
phenotypes and designs, like the age of onset of ADHD
symptoms (Lasky-Su et al. 2008a), conduct problems
(Anney et al. 2008b), and even a genome-wide gene–
environment interaction (G 9 E) study evaluating genetic
variants moderating the effects of maternal expressed
emotion on ADHD symptoms (and conduct problems;
Sonuga-Barke et al. 2008). In the following paragraphs, we
will discuss most of these studies and their most important
findings. The two studies exploring conduct problems in
the GAIN/IMAGE dataset (Anney et al. 2008b; Sonuga-
Barke et al. 2008) are beyond the scope of this review.
As mentioned above, most of the GWAS data so far are
derived from one sample of child–parent triads collected as
part of the IMAGE study. IMAGE is a consortium of
researchers from seven European countries and Israel.
IMAGE has ascertained more than 1,400 families through a
(preferentially combined subtype) ADHD-affected proband
(Brookes et al. 2006; Kuntsi et al. 2006). The probands
were required to be in the age range from 5 to 17 years. All
families were of European Caucasian descent. In all
families, both parents and at least one sibling, the latter not
selected for phenotype, were required to take part in the
study. IMAGE participants were extensively phenotyped
for ADHD and comorbid disorders, using the Parental
Account of Childhood Symptoms (PACS) (Taylor et al.
1986), administered by centrally trained investigators. In
addition, rating scale measures were used, including the
Long Version of Conners’ Parent and Teacher Rating
Scales, as well as the parent and teacher version of the
Strength and Difficulties Questionnaires (SDQ) (Conners
2003). A standardized algorithm was applied to PACS to
derive each of the 18 DSM-IV ADHD items, and, taking
into account a number of Conners items, a clinical diag-
nosis was made. Exclusion criteria included a low IQ
(\70), autism, epilepsy, and brain or genetic disorders
known to mimic ADHD symptoms. In GAIN, 958 family
triads from IMAGE, including the proband and his/
her parents were analyzed (http://www.ncbi.nlm.nih.gov/
projects/gap/cgi-bin/study.cgi?study_id=phs000016.v1.p1).
DNA was isolated from blood by Rutgers Cell and DNA
Repository (http://www.rucdr.org/). The samples were
analyzed by Perlegen Sciences on a microarray specially
designed for GAIN. The array investigates approximately
600,000 SNPs able to capture information of close to 100%
of the common genetic variation in Caucasians (Neale et al.
2008a). Data cleaning of the genotyping results was per-
formed through the National Centre for Biotechnology
Information (NCBI), leaving 438,784 SNPs for analysis.
The first paper on the GAIN/IMAGE ADHD genome-
wide dataset was based on the 909 complete family triads,
for which full genotyping information was available (Neale
et al. 2008a). Of these families, 790 contained male pro-
bands, 119 female probands. A total of 845 probands had a
combined subtype ADHD diagnosis, the average number
of symptoms was 16.1. The TDT design was chosen for
this study which contained families recruited from all over
Europe and from Israel, based on its robustness against
population stratification. Earlier research by Neale et al.
(2008b) had shown that differences indeed existed between
the different genetic backgrounds of the IMAGE partici-
pants, especially with the Israeli families of European
Caucasian descent. In addition, the family controlled
design showed more stability in the presence of non-ran-
dom genotyping error in GAIN (Anney et al. 2008a). No
genome-wide significant results were observed (with the
highest P values at 7.45E-06), although a power analysis
presented in the paper suggests that the size of the dataset
would have been sufficient to detect at least one genome-
wide significant (P value 5.0E-08) finding for a genetic
variant with a minor allele frequency (MAF) of 0.2 causing
Hum Genet (2009) 126:13–50 15
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an odds ratio of 1.3. A table in the Neale et al. paper
presents the highest-ranking 25 SNPs (based on P value)
(see also Table 1 in this review).
In a TDT design, the number of observed transmissions
of a given allele of a SNP is compared to the expected
frequency under the assumption of no association (Spiel-
man and Ewens 1996). Performing the TDT, the authors
noted a highly significant imbalance in the number of
major and minor allele over-transmissions. Given the large
numbers of SNPs analyzed, these numbers would have
been expected to be similar. Removing additional SNPs
that had failed quality control in one of the other two
GWAS based on the Perlegen microarray improved this
imbalance partly, suggesting that genotyping error or
missingness is (at least partly) responsible for this effect.
Therefore, the authors repeated their analysis including a
correction factor. Comparison of the presented tables list-
ing the top-25 SNPs before and after correction shows that
this resulted in the loss of half of the listed SNPs and a
general downward correction of P values. Although, as the
authors state, it might be (too) early to explore the bio-
logical relevance of the strongest observed associations, it
is a fact that the list contains a number of very interesting
candidate genes for ADHD (Table 1), most notably those
genes that also show association in the GWAS of quanti-
tative ADHD-related phenotypes (Lasky-Su et al. 2008b),
as indicated in Table 1. Among these is a SNP close to
CNR1, which encodes the cannabinoid receptor 1, a gene
that falls into a linkage region for ADHD from a primary
analysis (Ogdie et al. 2004) and shows suggestive linkage
in meta-analysis (Zhou et al. 2008c). CNR1 was also found
associated with the disorder in candidate gene-based
association studies (Lu et al. 2008; Ponce et al. 2003).
Furthermore, association of CNR1 with alcohol and drug
abuse and dependence has been observed (Zuo et al. 2007).
Also of interest are the findings for the especially brain-
expressed cytoskeleton-organizer DCLK1 and the extra-
cellular matrix component SPOCK3, as well as the two
potassium-channel regulators KCNIP1 and KCNIP4
(Table 1).
In an attempt to maximize the power of the GAIN/
IMAGE family-based GWAS, Lasky-Su et al. (2008b)
published a study focusing on quantitative ADHD pheno-
types using the Family-based Association Test (FBAT)
suite of programs. Based on the 18 DSM-IV symptoms of
ADHD the authors constructed 3 quantitative phenotypes
using (1) the number of hyperactive–impulsive symptoms,
(2) the number of inattentive symptoms, and (3) the total
number of symptoms. These phenotypes were each tested
under three different genetic models (additive, dominant,
recessive). Furthermore, three additional quantitative traits
were constructed based on the Conners ADHD Rating
Scales and the PACS using FBAT-PC methodology (Lange
et al. 2004c). This approach constructs a slightly different
phenotype for every SNP in order to maximize the heri-
tability at this SNP. Association testing was subsequently
limited to the set of ten SNPs per genotype with the highest
power to detect association derived from a screening
algorithm in the program PBAT (Lange et al. 2004b; van
Steen and Lange 2005). In total, this study performed 18
GWAS, increasing the multiple testing burden; correction
for multiple testing was limited to the single GWAS.
In addition to increasing power, using symptoms or
rating scales as a basis for phenotype selection had the
advantage that hyperactive–impulsive and inattentive
symptoms could be assessed independently in the com-
bined subtype ADHD of the GAIN/IMAGE participants.
However, a prerequisite for this quantitative approach to be
valid is that ADHD is a disorder at the extreme of a con-
tinuum observed in the population. Evidence suggesting
that this is indeed true comes from twin studies showing
strong heritability of quantitative measures of ADHD
(Lasky-Su et al. 2008b, and references herein) as well as
from a proband–sibling comparison in IMAGE (Chen et al.
2008; Thapar et al. 2006). Starting from the cleaned GAIN
dataset, Lasky-Su restricted the analysis to 429,784 auto-
somal SNPs (as FBAT cannot handle X-linked markers)
and 909 complete families. 87% of the probands were
male, and the mean age of probands was 10.88 years. The
average total number of symptoms was 16.11, the number
of hyperactive–impulsive symptoms was 8.11 and the
number of inattentive ones was 7.98.
Two genome-wide significant findings (corrected for
single analysis) emerged from the formal tests, one for
rs6565113 in an intron of CDH13 associated under an
additive genetic model with the FBAT-PC-based pheno-
type derived from all ADHD symptoms, one for rs552655
in an intron of GFOD1 associated with the FBAT-PC
phenotype for inattentive symptoms (dominant model).
The CDH13 finding is especially interesting, since a SNP
near this gene also is part of the top-25 in the GWAS by
Neale et al. (2008a, b), though the two studies are not
entirely independent, of course, and the gene is also found
among the top-findings from the ADHD GWAS by Lesch
et al. (2008, see below) and falls into the only significant
ADHD linkage region identified in the recent meta-analysis
(Zhou et al. 2008c). Furthermore, association with SNPs in
CDH13 is one of the most consistent findings in genome-
wide studies on a wide variety of phenotypes related to
drug abuse and dependence (Uhl et al. 2008a, b), although
there is no clear indication, which region of the gene is
most important. Possibly, different regions or risk factors
might cause different phenotypes. CDH13 codes for cad-
herin 13 (or T-cadherin), a member of a family of cell–cell
adhesion proteins (Patel et al. 2003), in addition to being a
regulator of neural cell growth. CDH13 shows a brain
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expression profile consistent with a role in ADHD, being
expressed in regions showing volumetric reductions in
patients with this disorder (Takeuchi et al. 2000; Takeuchi
and Ohtsuki 2001; Valera et al. 2007). Very little is known
about the second associated gene, GFOD1 and its product,
glucose–fructose oxidoreductase-domain containing 1,
except that it is expressed in brain and possibly plays a role
in electron transport (Lasky-Su et al. 2008b).
In addition to the formal testing of ten SNPs for each
phenotype Lasky-Su and coworkers also report a more
exploratory analysis of all SNPs in the dataset. There were
58 association findings with P values smaller than 10-5, of
which 46 SNPs were unique. Some SNPs showed associ-
ation under more than one genetic model and/or across
phenotypes. Although none of the SNPs listed here are
genome-wide significantly associated with ADHD, a high
percentage of the SNPs is present in brain-expressed genes
and/or in linkage regions for ADHD and other psychiatric
disorders (see Table 2). A particularly interesting finding
from this set includes the SNP in NOS1, encoding the
neuronal form of nitric oxide synthase. NO acts as the
second messenger of the N-methyl-D-aspartate receptor and
interacts with both the dopaminergic as well as the sero-
tonergic system in the human brain. NOS1 has been asso-
ciated with impulsive and aggressive behavior and ADHD
(Reif et al. 2009). Association has also been noted with
Alzheimer’s disease (Galimberti et al. 2008) and schizo-
phrenia, as well as with related neuropsychological per-
formance (Reif et al. 2006).
Lasky-Su and colleagues also reported P values for a
selection of predefined (classic) ADHD candidate genes
(Brookes et al. 2006). Most significant findings with P
values in the range of 10-5 were observed for SLC9A9.
This gene (which was with a total of 181 SNPs the largest
gene analyzed) also contained the largest number of asso-
ciations in terms of SNPs and phenotypes. Other findings at
P values of 10-4 were for DDC and SNAP25. The SLC6A1,
ADRB2, HTR1E, ADRA1A, DBH, BDNF, DRD2, TPH2,
HTR2A, SLC6A2, PER1, CHRNA4, COMT and SYT1 genes
showed association at 10-3. SLC9A9 encodes a sodium/
hydrogen exchanger and may be a particularly viable
candidate gene for ADHD. It was originally reported dis-
rupted in a patient with ADHD (de Silva et al. 2003) and
also shows mutations in patients with autism (Morrow et al.
2008) as well as having been found in multiple GWAS for
addiction-related disorders (Uhl et al. 2008a, b).
A GWAS not based on the GAIN/IMAGE sample was
published by Lesch et al. (2008). In their study they ana-
lyzed 343 German patients with persistent ADHD (mean
age 32.9 years with a range from 18 to 65, 54.5% male,
61.5% combined subtype, 31.2% inattentive subtype, 7.3%
hyperactive–impulsive subtype) and 304 controls (mean
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Structured Clinical Interview of DSM-IV axis 1 disorders
(SCID-I; Jacob et al. 2007), supported by ratings from the
Wender Utah Rating Scale and an ADHD diagnostic
checklist applying DSM-IV criteria categorically and
dimensionally (ADHD-DC) (Rosler et al. 2004). Comor-
bidity along the entire spectrum was analyzed using SCID-
I and SCID-II, the latter assessing axis II disorders. Life-
time comorbidity with major depression was 44.7%, with
substance use disorders it was 44.1% (of which 32.0% for
cannabis use, 40.6% for alcohol use). Of the 304 controls
only 54 were screened for psychiatric disorders prior to
inclusion. Genotyping was on the Affymetrix GeneChip
Human Mapping 500K sets. Importantly, instead of geno-
typing individual samples, pools were constructed of the
343 cases and 304 controls, respectively. For each pool
nine technical replicates were analyzed. After data cleaning
the authors ended up with allele frequencies for 504,219
SNPs, of which the autosomal SNPs were ranked based on
the mean of rankings performed using ANOVA, rank sums
and silhouette scores. Whereas the other ADHD GWAS
reports relied strictly on statistical rankings to describe
their results, Lesch and coworkers used additional criteria
for further prioritization of SNPs for follow up, one being
localization within or near genes (±100 kb flanking
region), a second being presence in clusters of at least three
SNPs located in regions of genes, a third being the com-
parison with a family-based association study performed in
a dataset from a recently published linkage paper by the
same group, or being present in a suggestive linkage region
from this analysis in adult ADHD patients (Romanos et al.
2008). In addition, expression in brain, as well as earlier
findings suggesting involvement in complex traits and
neuropsychiatric disorders (especially substance use dis-
orders) were taken into consideration.
Although none of the findings were genome-wide sig-
nificant, interesting candidate genes for ADHD are repor-
ted in this paper, too. Of the 80 top-ranked SNP findings,
30 fall into genes, of which nearly all are known to be
expressed in brain (see Table 3). A second list, containing
the top-10 of those genes with 3 or more SNPs among the
1,000 highest-ranking findings contains the genes KALRN
(15 SNPs), ZNF354C (15 SNPs), WRNIP1 (14 SNPs),
GRB10 (10 SNPs), DPP6 (7 SNPs), ARHGAP22 (11
SNPs), RAB38 (11 SNPs), FAT3 (8 SNPs), DA259379 (13
SNPs), NT5DC3 (20 SNPs). A third list summarizes all
findings that show overlap with the linkage analysis in
adult ADHD patients published earlier by the same group
(Romanos et al. 2008), and in some instances also a family-
based GWAS based on the 50 K linkage dataset (Table 3
in Lesch et al. 2008). Of the 30 genes listed there, 8 genes
(CTNNA2, MOBP, MAP1B, REEP5, ASTN2, ATP2C2,
CDH13 and ITGAE) overlap with the list of the 80 top-
ranked SNP findings, as indicated in Table 3. The authors
highlight the findings for ASTN2, CSMD2, ITGA11,
CTNNA2 and CDH13 in their discussion. All of these genes
have earlier shown association with substance use disorders
and related phenotypes, which is interesting in the light of
the frequent comorbidity with such disorders in (adult)
ADHD (44.1% in the current study). The five genes encode
proteins involved in cell adhesion and/or cell–cell com-
munication in development and maturation of the brain.
Also the UNC5B (Table 3) and KALRN genes fit into this
category. The latter encodes a protein present in the post-
synaptic density which regulates dendritic spine develop-
ment and is important for the neuronal plasticity underlying
memory and learning (Lesch et al. 2008; Penzes and Jones
2008).
Comparing this list with the findings from the other two
GWAS, very little overlap is seen (which might be
expected, given power limitations of the studies, see
below), except for one finding on chromosome 16, which
falls into CDH13. As indicated above, this gene was also
among the top-findings from both GAIN/IMAGE GWAS
studies, as well as many genome-wide studies of addiction
related phenotypes, recently reviewed by Uhl et al.
(2008a). An additional similarity to be noted is for two TLL
genes, TLL1 found among the top-ranks of the analysis
based in the categorical ADHD phenotype and showing
nominal association in the quantitative analyses by Lasky-
Su et al. (see Table V in Lasky-Su et al. 2008b), TLL2
present among the top-30 SNPs in gene regions in the
analysis by Lesch et al. Both genes encode metallopro-
teases that cleave collagen and are expressed in multiple
tissues including brain. A specific role in brain develop-
ment or functioning has not been reported for either of
these genes, though. Additional genes modulating the
extracellular matrix are found in all three studies, including
HAS3 (Lasky-Su et al. 2008b), SPOCK3 (Neale et al.
2008a), MAN2A2, GPC6 and MMP24 (Lesch et al. 2008).
A third interesting overlap is for genes related to potas-
sium-channel function, like the KCNC1 gene reported by
Lesch et al. (2008), the KCNIP1 and KCNIP4 genes
observed by Neale et al. (2008a)) and the DPP10 finding
for total ADHD symptom count (Lasky-Su et al. 2008b).
An exploratory analysis based on the GAIN/IMAGE
sample made use of the age of onset of hyperactive–
impulsive and inattentive symptoms, as assessed with a
question from the PACS interview, each, as an informative
phenotype for a GWAS (Lasky-Su et al. 2008a). Earlier
work of the authors had suggested that environmental
exposure outside the womb were less likely to contribute
significantly to the development of ADHD with a very
early age of onset (Lasky-Su et al. 2007). The number of
children included in the analysis was 930 with a mean age
of 10.86 years, 810 of them being males. The average age
at onset of ADHD symptoms was 2.67 years; for the
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hyperactive–impulsive symptoms this age was 2.77, for the
inattentive symptoms it was 4.31 years. The study inves-
tigated 429,784 autosomal SNPs using the FBAT-logrank
algorithm (Lange et al. 2004a) to identify genetic variants
that could predispose children to an earlier age of onset of
disease symptoms. Additive, dominant and recessive
genetic models were tested. A total of 16 SNPs reached P
values for association \10-5 including 14 unique findings
(Table 4). There is no overlap with the results from the
other GWAS. Although potentially due to chance it is
remarkable to see that this list contains a number of genes
that are involved in the response of the body to environ-
mental exposures and/or are regulated by the environment,
like the inflammation related ADAMTS2, the stress regu-
lator MAP3K7 or the vitamin A-responsive NAV2 gene.
An interesting new approach in GWAS is represented by
the exploratory study by Sonuga-Barke et al. (2008). The
author and his colleagues evaluated gene-environment
interactions (G 9 E) in ADHD in a genome-wide analysis.
Specifically, they investigated the effects of maternal
warmth and criticism on ADHD severity in the GAIN/
IMAGE dataset (also, a G 9 E analysis for conduct dis-
order symptoms is reported in the publication, but is not
reviewed here). ADHD symptoms were derived from the
PACS interview in IMAGE, maternal expressed emotion
was assessed using the Camberwell Family Interview.
Maternal warmth and criticism were coded, separately;
warmth was assessed by tone of voice, spontaneity, sym-
pathy and/or empathy toward the child. Criticism was
coded from statements that criticized or found fault with
the child based on the tone of voice and critical phrases
(Sonuga-Barke et al. 2008). Statistical analysis made use of
the FBAT-Interaction methodology (Vansteelandt et al.
2008). In total, 430,060 autosomal SNPs were included in
the analysis, as were 909 patients (87% males) from
complete trios. Mean age of the participants was
10.88 years, the average number of ADHD symptoms was
16.1, the mean overall measure for mother’s warmth
was 1.43 (range from 0 to 3) and for maternal criticism it
was 1.74 (range from 0 to 4). Additive, dominant and
recessive genetic models were tested for the phenotype and
the two environmental factors.
The analysis did not produce any genome-wide signifi-
cant findings, the highest P value reaching 9.08 9 10-7.
Nineteen SNPs showed interaction association P values
below 10-5 in the presence of main genetic effects (at
P B 10-5), of which five showed association under two
genetic models (Table 5). Only two findings were related
to maternal criticism. Most of the genes interacting with
maternal warmth clustered in three distinct regions on
chromosomes 6, 11 and 13. The regions on chromosomes 6
and 11 fall into genes, KIF6 and PIWIL4, respectively. The
region of 58 kb on chromosome 13 includes 8 association
findings for 4 unique SNPs, and although it does not con-
tain genes, it shows extensive LD extending proximally to
the SLC46A3 gene, the function of which is unknown.
Interestingly, the KIF6 gene has repeatedly been shown to
respond to environmental stimuli (Iakoubova et al. 2008b;
Iakoubova et al. 2008a; Shiffman et al. 2008). In the ref-
erenced studies, a coding variant in KIF6 altered the
response to statins in cardiovascular disease. The gene’s
role in moderating the influence of mother’s warmth on
ADHD severity will have to be investigated in further
detail. An additional six interaction associations at P values
of 10-4 were observed in the absence of genetic main
effects (Table V in Sonuga-Barke et al. 2008). Interest-
ingly, all but one finding were observed under a recessive
genetic model, which strongly limited the number of
informative families. Of these associations, only one was
for mother’s warmth. This finding falls into the BCAS1
gene on chromosome 20, which is a potential oncogene
with high expression in brain. Of the five association
findings interacting with mother’s criticism, especially a
finding on chromosome 2 is interesting, as it falls into the
MTA3 gene, which has two additional SNPs associated
with ADHD in the GWAS for quantitative phenotypes
(Lasky-Su et al. 2008b). The authors also tested potential
G 9 E effects for the list of ADHD candidate genes
defined earlier (Brookes et al. 2006). Interaction associa-
tion P values are most significant for DDC (mother’s
warmth and criticism), HTR2A and SLC9A9 (warmth) at
10-4.
The interpretation of the analytical strategy used in this
study is difficult. First of all, the direction of causation is
not clear: it could be that maternal expressed emotion
influences ADHD severity in the child, on the other hand, a
child with severe ADHD might also elicit more
pronounced criticism and less warmth from parents.
Furthermore, explaining the biological effects of the
environmental moderators of ADHD severity is not
straightforward. The authors discuss epigenetic effects
(like DNA methylation) as possible mechanisms. This
might indeed be supported by at least one of their findings:
PIWIL4 plays a role in chromatin-modification, another
epigenetic regulator of gene expression (Szyf et al. 2007,
2008).
Taking together all results from the GWAS performed in
ADHD, the following is to be remarked: none of the
findings so far show genome-wide significant association
with ADHD according to the thresholds currently handled
(Dudbridge and Gusnanto 2008; Pe’er et al. 2008; van
Steen and Lange 2005). Nevertheless, the most high-
ranking findings from the different studies contain inter-
esting new candidates for further study. Little overlap is
observed between studies, except for CDH13, which is
found in three studies (Lasky-Su et al. 2008b; Lesch et al.
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2008; Neale et al. 2008a). None of the ‘classic’ candidate
genes for ADHD are found among the top-findings of
either study, although two more recently reported genes,
NOS1 and CNR1, are observed at least once. In the can-
didate gene analyses reported for the GAIN/IMAGE sam-
ple, most evidence is repeatedly found for involvement of
SLC9A9 in ADHD. For all studies discussed here, overlap
with results from linkage studies reported in ADHD and
linkage as well as GWAS in other psychiatric disorders is
multiple.
Looking at the processes potentially involved in the
etiology of ADHD, little evidence (as yet) points to a direct
involvement of neurotransmitters (at least the classic
dopaminergic, noradrenergic and serotonergic pathways)
or regulators of neurotransmission (except for DNM1).
Some suggestions are found for involvement of ‘new’
neurotransmission and cell–cell communication systems,
though, like glutamate, vasopressin, and TAFA proteins.
Also, the potential involvement of potassium channel
subunits and regulators definitely warrants further investi-
gation. However, more basic processes also seem involved,
like cell division, adhesion (especially via cadherin and
integrin systems), neuronal migration, and neuronal plas-
ticity, as well as related transcription, cell polarity and
extracellular matrix regulation, and cytoskeletal remodel-
ing processes. Our conclusion is consistent with and
extends the conclusion drawn by Lesch and coworkers
based on the findings from their GWAS, in which they
suggest that neuronal spine formation and plasticity may
underlie the pathophysiology of ADHD. Finding inflam-
matory genes (IL16 and ADAMTS2) is somewhat surpris-
ing, although inflammation is already known to be involved
in different psychiatric disorders, like major depression and
Alzheimer’s disease (Anisman 2009; Bazar et al. 2006;
Garcia-Bueno et al. 2008; Serretti et al. 2007). The analysis
of age of onset of ADHD revealed a number of environ-
mentally regulated genes (Lasky-Su et al. 2008a), which
may suggest a particularly important influence of the
environment in this aspect of the disorder. However, all of
these biological hypotheses must be tempered by the
limited knowledge of the genetic architecture of ADHD at
this point. Currently, we do not have sufficient information
to draw strong conclusions about the relative impact of the
biological pathways and genetic influences, aside from
likely knowing that the genetic effects are modest in size.
In the last 2 years, much progress has been made in
identifying genes for psychiatric disorders through GWAS.
From the studies so far it has become apparent that early
power estimates have been far too optimistic and at least
several thousands of samples will be needed for the design
of an optimal study (Burton et al. 2008). Genetic hetero-
geneity appears even more extensive than previously
expected, with relative risks due to single genetic variants
in the range of 1.05–1.1 or even smaller (Ferreira et al.
2008; Neale et al. 2008a; O’Donovan et al. 2008; Sklar
et al. 2008). ADHD is no exception to this, and so all of the
ADHD GWAS performed to date are highly underpowered.
In addition, Lesch and colleagues used a pooling design,
which reduces power by about 70% and puts limitations to
the genetic models that can be investigated (Lesch et al.,
2008). Furthermore, using controls unscreened for the
presence of psychiatric disorders can be expected to reduce
power, though the effect of this is modest, given that the
prevalence is at most 5% (McCarthy et al. 2008). The
X-chromosome was not analyzed in most of the studies,
due to a limitation of the FBAT-program. As a clear dif-
ference in prevalence of ADHD exists between genders,
this might still be an interesting target to look at.
An important issue in psychiatric disorders in general
and ADHD in particular is phenotypic heterogeneity. First,
psychiatric diagnosis must rely on clinical symptoms that,
without external validators, cannot be expected to reflect
biologically relevant concepts that are closely linked to
genes (Kuntsi et al. 2006; Thapar et al. 2006). Although the
instruments used to define psychiatric GWAS phenotypes
are generally chosen for high reliability, they have no
proven biological validity and will therefore (at best) result
in a more ‘noisy’ phenotype definition than most biological
tests (Craddock et al. 2008). More importantly, however,
the classical nosological approaches identify phenotypi-
cally distinct diseases, such as ADHD, substance abuse,
affective disorder and schizophrenia, though these exhibit
considerable overlap in symptomatology, clinical course,
and long-term outcome. ADHD is hardly ever the only
disorder a patient suffers from, comorbidity is the rule
rather than the exception. For example, reported frequen-
cies of depression and substance use disorders were also
high in the GWAS sample used by Lesch et al. (2008).
These factors severely hamper the power of genetic asso-
ciation studies and might explain why psychiatric genetics
has had an extremely modest track record in pinpointing
and characterizing susceptibility loci, even using the
GWAS approaches.
That said, what are the perspectives for genome-wide
association studies in ADHD? The results of the first
studies—though most not genome-wide significant—are
already very exciting and change the way in which we
think about genetic factors involved in ADHD etiology.
For now, GWAS holds the greatest promise for under-
standing the genetic architecture of ADHD! However, we
need to improve the design of these studies by increasing
sample size for more power and by further improving/
extending phenotypic assessment to better reflect and par-
tition the phenotypic complexity of the disorder. The for-
mer will only become possible through collaboration. As a
field, ADHD has the good fortune of having several
40 Hum Genet (2009) 126:13–50
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thousand samples collected world-wide, with collaborative
efforts supported by the National Institute of Mental
Health. Investigators with ADHD GWAS datasets are also
participating in the Psychiatric GWAS Consortium (PGC),
a confederation of 101 scientists from 11 countries and 48
institutions having GWAS datasets on ADHD, autism,
bipolar disorder, schizophrenia and major depression
(Psychiatric GWAS Consortium Steering Committee
2009). The PGC investigators have agreed to participate in
coordinated mega-analyses both within and across disor-
ders. Within 1 year, it is to be expected that a collaborative
GWAS with more than 4,000 cases can be carried out via
the PGC for ADHD. It is this spirit of collaboration that we
believe will be needed to achieve the breakthroughs in
genetic research that will ultimately help us discover new
pathophysiological pathways and targets for treatment.
Improving GWAS design through extension of pheno-
typic assessment could be done by taking characteristics
into consideration that we already know or suspect to play
a role in genetic susceptibility. Given the limits of the
nosological systems, subdividing ADHD according to
subtype will probably not be sufficient, as there is already
evidence of shared genetic factors between subtypes
(Faraone et al. 2000a; Thapar et al. 2006). Taking into
account comorbidity might deal with some of the limits of
the phenotypes, as a number of studies have suggested
that ADHD plus a specific comorbidity may constitute a
distinct subtype of ADHD (Faraone et al. 2000b; Faraone
2000; Faraone and Doyle 2001; Fliers et al. 2009;
Rasmussen et al. 2004; Smalley et al. 2000; Willcutt et al.
2000). A recent study in IMAGE can be used as an
example that this affects association findings: Zhou et al.
(2008b) showed that SLC6A3/DAT1 was only associated
with ADHD in the absence of conduct disorder. Another
example is gender; given the difference between sexes,
certain genetic risk factors can be expected to affect males
and females differently. That this affects association
studies has already been shown in ADHD (Biederman
et al. 2008; Guimaraes et al. 2007; Rommelse et al.
2008b) as well as other (related) psychiatric disorders
(Craig et al. 2004; Diamond 2007; Haefner et al. 2008;
Kendler 1998; Lang et al. 2008; Okamura et al. 2007;
Rucci et al. 2009). An additional potentially important
factor is age at diagnosis. It is well established that age
influences cognitive performance, with children perform-
ing worse in neuropsychological tests than adolescents
and adults (Addamo et al. 2007) on tasks that are relevant
to ADHD (Rommelse et al. 2008a). We and others have
presented evidence that age can modulate the association
of SLC6A3/DAT1 with ADHD, with different haplotypes
of the gene being associated with ADHD in childhood and
adulthood (Barkley et al. 2006; Elia and Devoto 2007;
Franke et al. 2008).
A more radical way of dealing with the shortcomings of
the nosological system is to look deeper into the possibili-
ties of using (ADHD) endophenotypes for GWAS. Endo-
phenotypes, or intermediate phenotypes, represent heritable
phenotypic constructs that are, presumably, more directly
affected by genes than clinical symptoms or disease cate-
gories (Gottesman and Gould 2003; Szatmari et al. 2007a;
Walters and Owen 2007). This should result in a stronger
association between causal genes and the endophenotype
than the clinical disease phenotype. The success of an
endophenotype strategy requires either a higher heritability
of the endophenotype compared to the disease phenotype
(which is generally not generally observed, Szatmari et al.
2007a) or a reduced complexity of the genetic architecture
of the endophenotype due to the involvement of less genes
(see Fig. 1). Endophenotypes for ADHD have been pro-
posed at different levels, e.g. those based on neuropsycho-
logical performance (Doyle et al. 2005; Rommelse 2008)
and those based on neuroimaging (Castellanos and Tannock
2002), i.e. brain activity and structure. Recent genome-wide
linkage studies of neuropsychological endophenotypes for
ADHD indeed suggest that these measure offer increased
power for finding loci compared to clinical phenotypes
(Doyle et al. 2008; Rommelse et al. 2008c). A pooled
GWAS on memory performance also suggests this (Pap-
assotiropoulos et al. 2006). ‘Imaging genetics’ studies
would be thought to be particularly powerful, requiring
even smaller sample sizes (Dreher et al. 2008; van Haren
et al. 2008). Studies using such ADHD endophenotypes for
GWAS are currently ongoing.
An additional aspect to be taken into consideration in
GWAS is the potential role of G 9 E and gene–gene
(G 9 G) interactions in the etiology of ADHD. As the
exploratory analysis by Sonuga-Barke et al. (2008) shows,
this type of analysis will help to further delineate mecha-
nisms moderating disease severity and those leading to
disease.
A last aspect to be discussed relates to the genetic
models currently used in ADHD research. Up to now, we
work under the assumption that the ‘common disease,
common variant’ model will hold for ADHD. This model
suggests that ADHD is caused by multiple variants that are
common in the population and each contribute a small
amount of disease risk. However, experience from GWAS
in other multifactorial disorders now challenges this view
and postulates the existence of rare genetic variants con-
tributing to disease, that are not captured by GWAS (see
also McCarthy et al. 2008 for a more elaborate discussion
of this subject). This case of the ‘missing heritability’
might imply that private or low-frequency variants of large
effect size exist and actually explain most of the herita-
bility of a multifactorial disorder in individual patients.
Copy number variants (CNVs) might contribute a part of
Hum Genet (2009) 126:13–50 41
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this puzzle. CNVs include insertions, deletions and dupli-
cations and encompass relatively large genomic segments
of 1 kb to several Mb in size (Redon et al. 2006; Sebat
et al. 2004). Although they are a frequent class of poly-
morphism in the human genome, most CNVs are rare.
Many reports indeed now suggest involvement of CNVs in
psychiatric disorders (Lachman et al. 2007; Marshall et al.
2008; Sebat et al. 2007; Stefansson et al. 2002, 2008;
Szatmari et al. 2007b; Ullmann et al. 2007; Vrijenhoek
et al. 2008; Walsh et al. 2008; Weiss et al. 2008). The role
of CNVs in ADHD has not been studied, yet.
In conclusion, the GWAS performed so far in ADHD,
though far from conclusive, provide a first glimpse at genes
for the disorder. Many more (much larger studies) will be
needed. For this, collaboration between researchers as well
as standardized protocols for phenotyping and DNA-col-
lection will become increasingly important. Furthermore,
understanding how the genes identified by GWAS con-
tribute to ADHD risk, will require smart biological
experiments facing the challenge of an organ as inacces-
sible and complex as the human brain.
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which per-
mits any noncommercial use, distribution, and reproduction in any
medium, provided the original author(s) and source are credited.
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